| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.797 | 0.012 | 0.797 | Caspase 9 stimulant | |||
| 0.755 | 0.022 | 0.755 | Apoptosis agonist | 0.344 0.142 CID_154699587 | ||
| 0.668 | 0.005 | 0.668 | Antimitotic | |||
| 0.611 | 0.012 | 0.611 | Immunosuppressant | 0.33 0.097 CID_154699587 | ||
| 0.602 | 0.003 | 0.602 | T cell inhibitor | |||
| 0.6 | 0.01 | 0.6 | Caspase 3 stimulant | |||
| 0.448 | 0.01 | 0.448 | Tubulin antagonist | |||
| 0.454 | 0.04 | 0.454 | GABA C receptor rho-3 antagonist | |||
| 0.429 | 0.023 | 0.429 | DNA damaging | 0.186 0.127 CID_154699587 | ||
| 0.445 | 0.059 | 0.445 | Antibacterial | 0.436 0.062 CID_154699587 | ||
| 0.38 | 0.025 | 0.38 | Sigma receptor agonist | |||
| 0.349 | 0.004 | 0.349 | ATPase inhibitor | |||
| 0.403 | 0.074 | 0.472 | Histamine release inhibitor | 0.472 0.04 CID_154699587 | CID_154699587 | |
| 0.348 | 0.023 | 0.348 | ErbB-1 antagonist | |||
| 0.379 | 0.065 | 0.379 | Thioredoxin glutathione reductase inhibitor | |||
| 0.32 | 0.009 | 0.32 | Antineoplastic antibiotic | 0.073 0.062 CID_154699587 | ||
| 0.404 | 0.097 | 0.404 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.39 | 0.084 | 0.39 | 5 Hydroxytryptamine release inhibitor | |||
| 0.337 | 0.05 | 0.337 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.288 | 0.016 | 0.288 | Interleukin 6 antagonist | |||
| 0.295 | 0.047 | 0.295 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.257 | 0.011 | 0.257 | Nav1.1 sodium channel blocker | |||
| 0.308 | 0.064 | 0.308 | Aldehyde oxidase inhibitor | |||
| 0.256 | 0.019 | 0.256 | Heat shock protein 90 antagonist | |||
| 0.24 | 0.006 | 0.24 | MAP3K9 inhibitor | |||
| 0.297 | 0.071 | 0.297 | 5 Hydroxytryptamine release stimulant | |||
| 0.238 | 0.017 | 0.238 | Cystathionine beta-synthase inhibitor | |||
| 0.254 | 0.036 | 0.254 | Neurotrophic factor enhancer | |||
| 0.276 | 0.06 | 0.276 | Antiamyloidogenic | |||
| 0.219 | 0.005 | 0.219 | MAP3K7 inhibitor | |||
| 0.282 | 0.069 | 0.289 | Antioxidant | 0.289 0.066 CID_154699587 | CID_154699587 | |
| 0.225 | 0.015 | 0.225 | Microtubule formation inhibitor | |||
| 0.264 | 0.056 | 0.264 | Tyrosine 3 hydroxylase inhibitor | 0.193 0.148 CID_154699587 | ||
| 0.233 | 0.026 | 0.233 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.236 | 0.032 | 0.236 | Heat shock protein 90 alpha antagonist | |||
| 0.293 | 0.099 | 0.293 | Calcium channel activator | |||
| 0.204 | 0.013 | 0.204 | Antineoplastic alkaloid | |||
| 0.196 | 0.01 | 0.196 | Sphingomyelinase inhibitor | |||
| 0.237 | 0.055 | 0.237 | Nitric oxide antagonist | |||
| 0.19 | 0.01 | 0.19 | Estrogen receptor beta antagonist | |||
| 0.183 | 0.009 | 0.183 | Interleukin 2 antagonist | |||
| 0.184 | 0.015 | 0.184 | Estrogen antagonist | |||
| 0.17 | 0.004 | 0.17 | ATPase (Vacuolar H+) inhibitor | 0.123 0.017 CID_154699587 | ||
| 0.162 | 0.006 | 0.162 | Dopamine D5 antagonist | |||
| 0.162 | 0.008 | 0.162 | Thioredoxin reductase inhibitor | |||
| 0.201 | 0.048 | 0.201 | Succinate dehydrogenase inhibitor | |||
| 0.267 | 0.115 | 0.279 | Transcription factor NF kappa B inhibitor | 0.279 0.107 CID_154699587 | CID_154699587 | |
| 0.205 | 0.054 | 0.205 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.172 | 0.021 | 0.172 | Photosensitizer | |||
| 0.208 | 0.057 | 0.609 | Peroxidase inhibitor | 0.609 0.004 CID_154699587 | CID_154699587 | |
| 0.266 | 0.118 | 0.266 | Vasodilator, coronary | |||
| 0.225 | 0.077 | 0.225 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.19 | 0.043 | 0.19 | Arachidonic acid antagonist | |||
| 0.164 | 0.019 | 0.164 | Ca2+-transporting ATPase inhibitor | |||
| 0.15 | 0.01 | 0.15 | Glutamate release inhibitor | |||
| 0.156 | 0.017 | 0.156 | Acetylcholine M3 receptor agonist | |||
| 0.185 | 0.047 | 0.185 | Interferon gamma antagonist | |||
| 0.171 | 0.037 | 0.348 | Alkylator | 0.348 0.01 CID_154699587 | CID_154699587 | |
| 0.164 | 0.032 | 0.164 | Beta amyloid protein antagonist | |||
| 0.173 | 0.048 | 0.173 | GABA C receptor rho-2 antagonist | |||
| 0.219 | 0.095 | 0.276 | DNA synthesis inhibitor | 0.276 0.053 CID_154699587 | CID_154699587 | |
| 0.151 | 0.029 | 0.151 | UDP-glucose 4-epimerase inhibitor | |||
| 0.153 | 0.04 | 0.153 | Topoisomerase I inhibitor | |||
| 0.19 | 0.081 | 0.19 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.157 | 0.053 | 0.157 | Nav1.2 sodium channel blocker | |||
| 0.155 | 0.053 | 0.155 | M17 leucyl aminopeptidase inhibitor | |||
| 0.196 | 0.095 | 0.196 | Nitric-oxide synthase stimulant | |||
| 0.2 | 0.1 | 0.2 | RNA-directed DNA polymerase inhibitor | |||
| 0.119 | 0.019 | 0.119 | Estrogen receptor alpha antagonist | |||
| 0.136 | 0.038 | 0.136 | GABA C receptor antagonist | |||
| 0.159 | 0.062 | 0.159 | Protein kinase stimulant | |||
| 0.128 | 0.033 | 0.128 | Prolactin inhibitor | |||
| 0.233 | 0.138 | 0.233 | Cholesterol antagonist | |||
| 0.12 | 0.027 | 0.12 | CYP2A6 inhibitor | |||
| 0.103 | 0.011 | 0.103 | Estrogen receptor beta agonist | |||
| 0.11 | 0.024 | 0.11 | Glycine receptor antagonist | |||
| 0.116 | 0.031 | 0.116 | NADH dehydrogenase inhibitor | |||
| 0.124 | 0.038 | 0.124 | Creatine kinase inhibitor | |||
| 0.19 | 0.106 | 0.19 | Free radical scavenger | 0.176 0.118 CID_154699587 | ||
| 0.095 | 0.012 | 0.095 | Exportin-1 inhibitor | |||
| 0.148 | 0.066 | 0.148 | Adenylate cyclase stimulant | 0.135 0.091 CID_154699587 | ||
| 0.12 | 0.039 | 0.142 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.142 0.029 CID_154699587 | CID_154699587 | |
| 0.126 | 0.046 | 0.126 | GABA C receptor agonist | |||
| 0.119 | 0.04 | 0.119 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.11 | 0.033 | 0.11 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.103 | 0.03 | 0.103 | mTOR complex 2 inhibitor | |||
| 0.121 | 0.049 | 0.121 | Alpha 2c adrenoreceptor antagonist | |||
| 0.115 | 0.044 | 0.115 | GABA C receptor rho-1 antagonist | |||
| 0.122 | 0.052 | 0.122 | Ferrochelatase inhibitor | |||
| 0.125 | 0.055 | 0.125 | Alpha 2b adrenoreceptor antagonist | |||
| 0.133 | 0.065 | 0.133 | c-Src kinase inhibitor | |||
| 0.109 | 0.044 | 0.109 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.144 | 0.079 | 0.144 | NOS3 expression enhancer | |||
| 0.068 | 0.003 | 0.068 | Alpha 2a adrenoreceptor agonist | |||
| 0.085 | 0.021 | 0.085 | Estrogen agonist | |||
| 0.106 | 0.043 | 0.106 | Triose-phosphate isomerase inhibitor | |||
| 0.091 | 0.03 | 0.091 | Phenylalanine 4-hydroxylase inhibitor | 0.091 0.03 CID_154699587 | ||
| 0.189 | 0.13 | 0.313 | Superoxide dismutase inhibitor | 0.313 0.046 CID_154699587 | CID_154699587 | |
| 0.081 | 0.023 | 0.081 | Glutamate (mGluR6) antagonist | |||
| 0.122 | 0.063 | 0.122 | Cholesterol synthesis inhibitor | |||
| 0.143 | 0.085 | 0.143 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.11 | 0.053 | 0.149 | Adenylate kinase inhibitor | 0.149 0.027 CID_154699587 | CID_154699587 | |
| 0.145 | 0.089 | 0.145 | Melanin inhibitor | |||
| 0.081 | 0.026 | 0.081 | Glutamate (mGluR7) antagonist | |||
| 0.074 | 0.022 | 0.074 | Protein 50S ribosomal subunit inhibitor | |||
| 0.088 | 0.037 | 0.088 | Phosphofructokinase-1 inhibitor | |||
| 0.083 | 0.035 | 0.083 | Glycine receptor agonist | |||
| 0.135 | 0.087 | 0.135 | Pregnane X receptor agonist | |||
| 0.081 | 0.033 | 0.081 | Phospholipase D inhibitor | |||
| 0.104 | 0.057 | 0.128 | Anabolic | 0.128 0.032 CID_154699587 | CID_154699587 | |
| 0.205 | 0.158 | 0.291 | Immunomodulator | 0.291 0.087 CID_154699587 | CID_154699587 | |
| 0.06 | 0.014 | 0.06 | Microtubule stabilization | |||
| 0.228 | 0.184 | 0.228 | 15-Lipoxygenase inhibitor | |||
| 0.092 | 0.048 | 0.092 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.101 | 0.059 | 0.101 | mTOR complex 1 inhibitor | |||
| 0.055 | 0.013 | 0.055 | Glucocorticoid antagonist | |||
| 0.068 | 0.027 | 0.068 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.049 | 0.008 | 0.049 | ATP citrate lysase inhibitor | |||
| 0.071 | 0.031 | 0.071 | Alpha 2 adrenoreceptor agonist | |||
| 0.062 | 0.024 | 0.062 | Aconitate hydratase inhibitor | |||
| 0.066 | 0.029 | 0.066 | Fatty acid synthase inhibitor | |||
| 0.101 | 0.066 | 0.101 | MAP kinase kinase kinase inhibitor | |||
| 0.115 | 0.08 | 0.115 | Nav1.3 sodium channel blocker | |||
| 0.056 | 0.022 | 0.056 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.065 | 0.033 | 0.065 | Heat shock protein 90 beta antagonist | |||
| 0.174 | 0.142 | 0.174 | Spasmolytic | |||
| 0.04 | 0.008 | 0.04 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.07 | 0.039 | 0.07 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.06 | 0.029 | 0.06 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.133 | 0.103 | 0.133 | MAP kinase kinase 4 inhibitor | |||
| 0.087 | 0.057 | 0.087 | Androgen antagonist | |||
| 0.186 | 0.156 | 0.186 | Lipoxygenase inhibitor | |||
| 0.124 | 0.094 | 0.124 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.203 | 0.174 | 0.325 | Antithrombotic | 0.325 0.074 CID_154699587 | CID_154699587 | |
| 0.101 | 0.073 | 0.101 | DNA intercalator | |||
| 0.056 | 0.03 | 0.056 | Heparanase inhibitor | |||
| 0.031 | 0.005 | 0.031 | Alpha 2c adrenoreceptor agonist | |||
| 0.031 | 0.007 | 0.031 | Imidazoline I1 receptor antagonist | |||
| 0.065 | 0.041 | 0.065 | Calcium channel P-type blocker | |||
| 0.133 | 0.11 | 0.133 | CF transmembrane conductance regulator agonist | |||
| 0.075 | 0.052 | 0.075 | Alpha 2a adrenoreceptor antagonist | |||
| 0.074 | 0.051 | 0.074 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.152 | 0.13 | 0.243 | Insulin sensitizer | 0.243 0.039 CID_154699587 | CID_154699587 | |
| 0.063 | 0.04 | 0.084 | Carbamoyl phosphate synthetase inhibitor | 0.084 0.027 CID_154699587 | CID_154699587 | |
| 0.031 | 0.01 | 0.031 | Sodium/glucose cotransporter inhibitor | |||
| 0.042 | 0.023 | 0.042 | Alpha 1d adrenoreceptor agonist | |||
| 0.051 | 0.032 | 0.051 | Squalene epoxidase inhibitor | |||
| 0.054 | 0.035 | 0.054 | Alpha-mannosidase inhibitor | |||
| 0.152 | 0.134 | 0.152 | Aryl hydrocarbon receptor agonist | |||
| 0.109 | 0.091 | 0.109 | Cathepsin H inhibitor | |||
| 0.098 | 0.08 | 0.098 | DOPA decarboxylase inhibitor | |||
| 0.087 | 0.07 | 0.087 | Protein kinase C zeta inhibitor | |||
| 0.045 | 0.029 | 0.045 | Geranyltranstransferase inhibitor | |||
| 0.097 | 0.082 | 0.097 | Protein kinase C gamma inhibitor | |||
| 0.036 | 0.023 | 0.036 | Estrogen receptor alpha agonist | |||
| 0.054 | 0.041 | 0.054 | Alcohol oxidase inhibitor | |||
| 0.07 | 0.057 | 0.196 | Glutamate dehydrogenase inhibitor | 0.196 0.01 CID_154699587 | CID_154699587 | |
| 0.025 | 0.012 | 0.025 | CC chemokine 8 receptor antagonist | |||
| 0.047 | 0.035 | 0.047 | Mineralocorticoid receptor antagonist | |||
| 0.056 | 0.045 | 0.056 | Biliverdin reductase inhibitor | |||
| 0.015 | 0.004 | 0.015 | Progesterone receptor A antagonist | |||
| 0.08 | 0.07 | 0.08 | D-Ala-D-Ala ligase inhibitor | |||
| 0.062 | 0.052 | 0.062 | Neuronal nicotinic receptor antagonist | |||
| 0.015 | 0.005 | 0.015 | Imidazoline I2 receptor antagonist | |||
| 0.051 | 0.041 | 0.051 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.048 | 0.039 | 0.074 | CD45 antagonist | 0.074 0.014 CID_154699587 | CID_154699587 | |
| 0.051 | 0.042 | 0.051 | Myc inhibitor | |||
| 0.097 | 0.089 | 0.097 | DNA polymerase I inhibitor | |||
| 0.055 | 0.048 | 0.055 | Androgen agonist | |||
| 0.016 | 0.009 | 0.016 | Antibiotic Macrolide-like | |||
| 0.038 | 0.032 | 0.038 | Acid-sensing ion channel blocker | |||
| 0.021 | 0.015 | 0.021 | Adenosine kinase inhibitor | |||
| 0.043 | 0.038 | 0.043 | Adenylate cyclase 1 inhibitor | |||
| 0.101 | 0.097 | 0.131 | Aldehyde dehydrogenase inhibitor | 0.131 0.061 CID_154699587 | CID_154699587 | |
| 0.076 | 0.072 | 0.076 | Alpha 2 adrenoreceptor antagonist | |||
| 0.071 | 0.067 | 0.071 | Acetylcholine nicotinic antagonist | |||
| 0.036 | 0.034 | 0.036 | Dopamine D5 agonist | |||
| 0.129 | 0.127 | 0.129 | Heat shock protein 70 antagonist | |||
| 0.137 | 0.135 | 0.53 | Phospholipase C inhibitor | 0.53 0.005 CID_154699587 | CID_154699587 | |
| 0.048 | 0.047 | 0.048 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.04 | 0.039 | 0.04 | Mannosidase inhibitor | |||
| 0.025 | 0.024 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.062 | 0.066 | 0.176 | Aminopeptidase I inhibitor | 0.176 0.009 CID_154699587 | CID_154699587 | |
| 0.084 | 0.089 | 0.236 | Expectorant | 0.236 0.014 CID_154699587 | CID_154699587 | |
| 0.149 | 0.155 | 0.593 | Immunostimulant | 0.593 0.017 CID_154699587 | CID_154699587 | |
| 0.058 | 0.065 | 0.43 | Histidine decarboxylase inhibitor | 0.43 0.004 CID_154699587 | CID_154699587 | |
| 0.061 | 0.069 | 0.261 | Glutamate decarboxylase inhibitor | 0.261 0.004 CID_154699587 | CID_154699587 | |
| 0.113 | 0.122 | 0.12 | Protein-tyrosine phosphatase inhibitor | 0.12 0.113 CID_154699587 | CID_154699587 | |
| 0.041 | 0.054 | 0.045 | HCV NS3/NS4A protease inhibitor | 0.045 0.042 CID_154699587 | CID_154699587 | |
| 0.075 | 0.09 | 0.116 | Alcohol dehydrogenase inhibitor | 0.116 0.038 CID_154699587 | CID_154699587 | |
| 0.049 | 0.082 | 0.204 | Catalase inhibitor | 0.204 0.014 CID_154699587 | CID_154699587 | |
| 0.08 | 0.114 | 0.191 | Mucolytic | 0.191 0.015 CID_154699587 | CID_154699587 | |
| 0.064 | 0.104 | 0.342 | Aminopeptidase B inhibitor | 0.342 0.006 CID_154699587 | CID_154699587 | |
| 0.127 | 0.169 | 0.175 | Neurotensin receptor agonist | 0.175 0.056 CID_154699587 | CID_154699587 | |
| 0.056 | 0.098 | 0.09 | Ornithine decarboxylase inhibitor | 0.09 0.055 CID_154699587 | CID_154699587 | |
| 0.086 | 0.134 | 0.215 | Toll-Like receptor 2 antagonist | 0.215 0.018 CID_154699587 | CID_154699587 | |
| 0.027 | 0.076 | 0.131 | Ornithine carbamoyltransferase inhibitor | 0.131 0.011 CID_154699587 | CID_154699587 | |
| 0.112 | 0.168 | 0.397 | Hepatoprotectant | 0.397 0.013 CID_154699587 | CID_154699587 | |
| 0.025 | 0.081 | 0.079 | Thymidylate synthase inhibitor | 0.079 0.008 CID_154699587 | CID_154699587 | |
| 0.1 | 0.162 | 0.373 | Growth hormone agonist | 0.373 0.02 CID_154699587 | CID_154699587 | |
| 0.035 | 0.099 | 0.066 | Carbonic anhydrase stimulant | 0.066 0.034 CID_154699587 | CID_154699587 | |
| 0.016 | 0.08 | 0.031 | Calcitonin receptor agonist | 0.031 0.026 CID_154699587 | CID_154699587 | |
| 0.005 | 0.07 | 0.02 | Aminopeptidase A inhibitor | 0.02 0.01 CID_154699587 | CID_154699587 | |
| 0.068 | 0.133 | 0.147 | Adenylate cyclase inhibitor | 0.147 0.047 CID_154699587 | CID_154699587 | |
| 0.011 | 0.09 | 0.028 | Lysine carboxypeptidase inhibitor | 0.028 0.018 CID_154699587 | CID_154699587 | |
| 0.004 | 0.089 | 0.027 | Ileal bile acid transport inhibitor | 0.027 0.005 CID_154699587 | CID_154699587 | |
| 0.007 | 0.098 | 0.053 | Arginase inhibitor | 0.053 0.013 CID_154699587 | CID_154699587 | |
| 0.143 | 0.235 | 0.203 | Gastrin inhibitor | 0.203 0.145 CID_154699587 | CID_154699587 | |
| 0.053 | 0.152 | 0.214 | Glutathione S-transferase inhibitor | 0.214 0.005 CID_154699587 | CID_154699587 | |
| 0.016 | 0.116 | 0.149 | Toll-Like receptor 2 agonist | 0.149 0.011 CID_154699587 | CID_154699587 | |
| 0.157 | 0.258 | 0.353 | Apoptosis antagonist | 0.353 0.054 CID_154699587 | CID_154699587 | |
| 0.023 | 0.127 | 0.042 | AICAR transformylase inhibitor | 0.042 0.034 CID_154699587 | CID_154699587 | |
| 0.037 | 0.148 | 0.085 | Topoisomerase II alpha inhibitor | 0.085 0.05 CID_154699587 | CID_154699587 | |
| 0.088 | 0.202 | 0.134 | Vanilloid 1 agonist | 0.134 0.06 CID_154699587 | CID_154699587 | |
| 0.146 | 0.262 | 0.304 | Insulysin inhibitor | 0.304 0.056 CID_154699587 | CID_154699587 | |
| 0.097 | 0.218 | 0.242 | Interleukin agonist | 0.242 0.085 CID_154699587 | CID_154699587 | |
| 0.048 | 0.179 | 0.094 | Topoisomerase II inhibitor | 0.094 0.093 CID_154699587 | CID_154699587 | |
| 0.084 | 0.219 | 0.157 | Platelet adhesion inhibitor | 0.157 0.098 CID_154699587 | CID_154699587 | |
| 0.028 | 0.164 | 0.049 | Bombesin 2 receptor antagonist | 0.049 0.035 CID_154699587 | CID_154699587 | |
| 0.012 | 0.158 | 0.091 | Ribonucleoside-diphosphate reductase inhibitor | 0.091 0.021 CID_154699587 | CID_154699587 | |
| 0.011 | 0.158 | 0.054 | Antimetabolite | 0.054 0.029 CID_154699587 | CID_154699587 | |
| 0.011 | 0.159 | 0.092 | Ribonucleotide reductase inhibitor | 0.092 0.023 CID_154699587 | CID_154699587 | |
| 0.074 | 0.244 | 0.14 | Thiol protease inhibitor | 0.14 0.08 CID_154699587 | CID_154699587 | |
| 0.085 | 0.255 | 0.297 | Platelet antagonist | 0.297 0.054 CID_154699587 | CID_154699587 | |
| 0.011 | 0.218 | 0.076 | Glycine transporter 2 inhibitor | 0.076 0.019 CID_154699587 | CID_154699587 | |
| 0.012 | 0.22 | 0.058 | Neutrophil collagenase inhibitor | 0.058 0.053 CID_154699587 | CID_154699587 | |
| 0.06 | 0.275 | 0.174 | Phospholipase A2 inhibitor | 0.174 0.057 CID_154699587 | CID_154699587 | |
| 0.017 | 0.233 | 0.088 | Glucagon-like peptide 1 agonist | 0.088 0.029 CID_154699587 | CID_154699587 | |
| 0.071 | 0.291 | 0.157 | Hemostatic | 0.157 0.06 CID_154699587 | CID_154699587 | |
| 0.049 | 0.344 | 0.185 | Histone deacetylase SIRT1 inhibitor | 0.185 0.037 CID_154699587 | CID_154699587 | |
| 0.017 | 0.331 | 0.046 | Cathepsin F inhibitor | 0.046 0.019 CID_154699587 | CID_154699587 | |
| 0.029 | 0.407 | 0.145 | Bone formation stimulant | 0.145 0.063 CID_154699587 | CID_154699587 | |
| 0.036 | 0.437 | 0.435 | Interleukin antagonist | 0.435 0.026 CID_154699587 | CID_154699587 | |
| 0.012 | 0.44 | 0.068 | Analgesic, opioid | 0.068 0.064 CID_154699587 | CID_154699587 | |
| 0.039 | 0.475 | 0.187 | Vasodilator | 0.187 0.115 CID_154699587 | CID_154699587 | |
| 0.009 | 0.469 | 0.044 | Growth hormone release inhibitor | 0.044 0.027 CID_154699587 | CID_154699587 | |
| 0.013 | 0.484 | 0.044 | Glutamate (mGluR8) antagonist | 0.044 0.013 CID_154699587 | CID_154699587 | |
| 0.013 | 0.501 | 0.091 | Sirtuin 1 inhibitor | 0.091 0.027 CID_154699587 | CID_154699587 | |
| 0.017 | 0.527 | 0.162 | Chelator | 0.162 0.032 CID_154699587 | CID_154699587 | |
| 0.011 | 0.562 | 0.041 | Neurokinin 2 agonist | 0.041 0.029 CID_154699587 | CID_154699587 | |
| 0.012 | 0.571 | 0.079 | Cell adhesion molecule inhibitor | 0.079 0.055 CID_154699587 | CID_154699587 | |
| 0.015 | 0.6 | 0.113 | Histone deacetylase class III inhibitor | 0.113 0.076 CID_154699587 | CID_154699587 | |
| 0.011 | 0.631 | 0.146 | Aminoacyl-tRNA synthetase inhibitor | 0.146 0.02 CID_154699587 | CID_154699587 | |
| 0.015 | 0.636 | 0.09 | Somatostatin 1 agonist | 0.09 0.041 CID_154699587 | CID_154699587 | |
| 0.002 | 0.626 | 0.022 | Aminopeptidase P inhibitor | 0.022 0.018 CID_154699587 | CID_154699587 | |
| 0.018 | 0.672 | 0.143 | Insulin secretagoues | 0.143 0.081 CID_154699587 | CID_154699587 | |
| 0.005 | 0.666 | 0.046 | Endothelin-converting enzyme inhibitor | 0.046 0.033 CID_154699587 | CID_154699587 | |
| 0.005 | 0.67 | 0.048 | Aminopeptidase N inhibitor | 0.048 0.033 CID_154699587 | CID_154699587 | |
| 0.007 | 0.711 | 0.069 | Aminopeptidase microsomal inhibitor | 0.069 0.032 CID_154699587 | CID_154699587 | |
| 0.016 | 0.723 | 0.054 | Cathepsin E inhibitor | 0.054 0.05 CID_154699587 | CID_154699587 | |
| 0.013 | 0.721 | 0.146 | Cell adhesion inhibitor | 0.146 0.049 CID_154699587 | CID_154699587 | |
| 0.063 | 0.78 | 0.323 | Peptidyltransferase inhibitor | 0.323 0.018 CID_154699587 | CID_154699587 | |
| 0.016 | 0.743 | 0.078 | Adenine nucleotide translocase inhibitor | 0.078 0.01 CID_154699587 | CID_154699587 | |
| 0.001 | 0.733 | 0.016 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.016 0.009 CID_154699587 | CID_154699587 | |
| 0.004 | 0.74 | 0.162 | Selectin antagonist | 0.162 0.016 CID_154699587 | CID_154699587 | |
| 0.029 | 0.773 | 0.463 | Antiinflammatory | 0.463 0.104 CID_154699587 | CID_154699587 | |
| 0.013 | 0.77 | 0.056 | Carbonic anhydrase II stimulant | 0.056 0.029 CID_154699587 | CID_154699587 | |
| 0.02 | 0.797 | 0.172 | Hypoglycemic | 0.172 0.145 CID_154699587 | CID_154699587 | |
| 0.004 | 0.796 | 0.066 | Angiotensin-converting enzyme inhibitor | 0.066 0.023 CID_154699587 | CID_154699587 | |
| 0.03 | 0.834 | 0.426 | Sodium/bile acid cotransporter inhibitor | 0.426 0.011 CID_154699587 | CID_154699587 | |
| 0.006 | 0.811 | 0.053 | Erythropoietin receptor agonist | 0.053 0.02 CID_154699587 | CID_154699587 | |
| 0.046 | 0.855 | 0.355 | Interleukin 2 agonist | 0.355 0.043 CID_154699587 | CID_154699587 | |
| 0.009 | 0.825 | 0.058 | Bombesin 1 receptor agonist | 0.058 0.043 CID_154699587 | CID_154699587 | |
| 0.005 | 0.827 | 0.075 | Nitric oxide donor | 0.075 0.027 CID_154699587 | CID_154699587 | |
| 0.029 | 0.86 | 0.146 | Factor V inhibitor | 0.146 0.02 CID_154699587 | CID_154699587 | |
| 0.005 | 0.857 | 0.119 | Protease inhibitor | 0.119 0.048 CID_154699587 | CID_154699587 | |
| 0.005 | 0.857 | 0.617 | Anticoagulant | 0.617 0.005 CID_154699587 | CID_154699587 | |
| 0.006 | 0.862 | 0.05 | Cholecystokinin B agonist | 0.05 0.016 CID_154699587 | CID_154699587 | |
| 0.009 | 0.867 | 0.073 | Chymotrypsin inhibitor | 0.073 0.064 CID_154699587 | CID_154699587 | |
| 0.004 | 0.87 | 0.04 | Carbonic anhydrase I stimulant | 0.04 0.023 CID_154699587 | CID_154699587 | |
| 0.008 | 0.88 | 0.375 | Angiogenesis stimulant | 0.375 0.026 CID_154699587 | CID_154699587 | |
| 0.002 | 0.876 | 0.05 | Complement C3a chemotactic receptor antagonist | 0.05 0.027 CID_154699587 | CID_154699587 | |
| 0.022 | 0.906 | 0.12 | Folate antagonist | 0.12 0.039 CID_154699587 | CID_154699587 | |
| 0.006 | 0.905 | 0.05 | Neuropeptide agonist | 0.05 0.042 CID_154699587 | CID_154699587 | |
| 0.012 | 0.911 | 0.059 | Caspase 9 inhibitor | 0.059 0.048 CID_154699587 | CID_154699587 | |
| 0.004 | 0.917 | 0.055 | Cathepsin B inhibitor | 0.055 0.041 CID_154699587 | CID_154699587 | |
| 0.016 | 0.935 | 0.093 | Transcription factor NF kappa B stimulant | 0.093 0.047 CID_154699587 | CID_154699587 | |
| 0.012 | 0.941 | 0.163 | Hematopoietic | 0.163 0.014 CID_154699587 | CID_154699587 | |
| 0.004 | 0.945 | 0.043 | Neurotensin receptor antagonist | 0.043 0.033 CID_154699587 | CID_154699587 | |
| 0.008 | 0.951 | 0.109 | Nav1.4 sodium channel blocker | 0.109 0.063 CID_154699587 | CID_154699587 | |
| 0.002 | 0.949 | 0.048 | GP IIb/IIIa receptor antagonist | 0.048 0.034 CID_154699587 | CID_154699587 | |
| 0.005 | 0.956 | 0.346 | Thrombolytic | 0.346 0.017 CID_154699587 | CID_154699587 | |
| 0.002 | 0.961 | 0.032 | Bradykinin B2 receptor agonist | 0.032 0.017 CID_154699587 | CID_154699587 | |
| 0.002 | 0.973 | 0.03 | Protocollagen prolyl hydroxylase inhibitor | 0.03 0.015 CID_154699587 | CID_154699587 | |
| 0.004 | 0.982 | 0.088 | Factor XII inhibitor | 0.088 0.052 CID_154699587 | CID_154699587 | |
| 0.002 | 0.995 | 0.041 | Integrin alpha5beta1 antagonist | 0.041 0.028 CID_154699587 | CID_154699587 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |